Order Article Reprints

Cheung WY, Carbonell C, Navani V, Sangha RS, Ewara EM, Elia-Pacitti J, Iczkovitz S, Jarada TN, Warkentin MT. Real-World Treatment Patterns, Health Outcomes, and Healthcare Resource Use in Advanced Common EGFR-Positive Non-Small Cell Lung Cancer Patients Treated with Osimertinib in Alberta. Current Oncology. 2024; 31(8):4382-4396. https://doi.org/10.3390/curroncol31080327

Cheung, Winson Y., Chantelle Carbonell, Vishal Navani, Randeep S. Sangha, Emmanuel M. Ewara, Julia Elia-Pacitti, Sandra Iczkovitz, Tamer N. Jarada, and Matthew T. Warkentin. 2024. "Real-World Treatment Patterns, Health Outcomes, and Healthcare Resource Use in Advanced Common EGFR-Positive Non-Small Cell Lung Cancer Patients Treated with Osimertinib in Alberta" Current Oncology 31, no. 8: 4382-4396. https://doi.org/10.3390/curroncol31080327

Cheung, W. Y., Carbonell, C., Navani, V., Sangha, R. S., Ewara, E. M., Elia-Pacitti, J., Iczkovitz, S., Jarada, T. N., & Warkentin, M. T. (2024). Real-World Treatment Patterns, Health Outcomes, and Healthcare Resource Use in Advanced Common EGFR-Positive Non-Small Cell Lung Cancer Patients Treated with Osimertinib in Alberta. Current Oncology, 31(8), 4382-4396. https://doi.org/10.3390/curroncol31080327